This inventor holds 1 USPTO granted patent. Top assignee: Cephalon, Inc.. Active years: 2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001
Title: The Innovations of Michael S. Saporito
Introduction
Michael S. Saporito is an accomplished inventor based in Westmont, NJ (US). He has made significant contributions to the field of therapeutics, particularly through his work on the K-252a derivative. His innovative approach has led to the development of methodologies that hold promise for various therapeutic applications.
Latest Patents
Michael S. Saporito holds 1 patent for the use of a K-252a derivative. This patent discloses therapeutic methodologies utilizing a ring substituted derivative of the indolocarbazole K-252a. The derivative is represented by a specific chemical formula, showcasing his expertise in medicinal chemistry.
Career Highlights
Throughout his career, Saporito has been associated with Cephalon, Inc., a company known for its focus on developing innovative therapies. His work at Cephalon has allowed him to contribute to advancements in the pharmaceutical industry, particularly in the area of drug development.
Collaborations
Michael has collaborated with notable colleagues, including Thomas M. Engber and Forrest A. Haun. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to groundbreaking discoveries.
Conclusion
Michael S. Saporito's contributions to the field of therapeutics through his patent on the K-252a derivative exemplify his dedication to innovation. His work continues to influence the pharmaceutical landscape, paving the way for future advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile